Stroke

Acorda Milestone Stroke Study <- click for more information

Study Purpose: To determine the effect of two dose strengths of study medication taken twice daily for 12 weeks, on stable walking deficits in subjects with post-ischemic stroke.

Basic Eligibility Criteria:

  • Male and female patients between ages 18 and over
  • Must be 6 months post-ischemic stroke

Bipi Re-spect Study <- click for more information

Study Purpose: To demonstrate that the efficacy of dabigatran 110mg or 150mg BID is superior to ASA 100mg AD in prevention of stroke of undetermined source.

Basic Eligibility Criteria:

  • 60 yrs old or 50-59 with additonal risk factors
  • Modified Rankin Scale of >4 at time of randomization or inability to swallow medications.
  • Major risk cardioembolic source of embolism (more information can be found at the study title link).

                                               ---------------------

If you would like further information about any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff:

Irina Gamerman, M.D., Clinical Research Manager, at [email protected]

Clinical Research Coordinator:

 

Micah Sy at [email protected]

You may also call 203.333.1151 and we will be happy to answer any of your questions.